$2.33T
Total marketcap
$109.3B
Total volume
BTC 50.00%     ETH 15.43%
Dominance

Nu-Med Plus NUMD Stock

0.05 USD {{ price }} -0.408997% {{change_pct}}%
Exchange
Other OTC
Market Cap
4.07M USD
LOW - HIGH [24H]
0.03 - 0.05 USD
VOLUME [24H]
151.01K USD
{{ volume }}
P/E Ratio
0
Earnings per share
0 USD

Nu-Med Plus Price Chart

Nu-Med Plus NUMD Financial and Trading Overview

Nu-Med Plus stock price 0.05 USD
Previous Close 0.01 USD
Open 0.01 USD
Bid N/A x N/A
Ask N/A x N/A
Day's Range 0.01 - 0.01 USD
52 Week Range 0.009 - 0.07 USD
Volume 82K USD
Avg. Volume 19.37K USD
Market Cap 1.2M USD
Beta (5Y Monthly) 0.715845
PE Ratio (TTM) N/A
EPS (TTM) 0 USD
Forward Dividend & Yield N/A (N/A)
Ex-Dividend Date N/A
1y Target Est N/A

NUMD Valuation Measures

Enterprise Value 1.24M USD
Trailing P/E N/A
Forward P/E N/A
PEG Ratio (5 yr expected) N/A
Price/Sales (ttm) N/A
Price/Book (mrq) N/A
Enterprise Value/Revenue N/A
Enterprise Value/EBITDA -8.36

Trading Information

Nu-Med Plus Stock Price History

Beta (5Y Monthly) 0.715845
52-Week Change -8.12%
S&P500 52-Week Change 20.43%
52 Week High 0.07 USD
52 Week Low 0.009 USD
50-Day Moving Average 0.01 USD
200-Day Moving Average 0.02 USD

NUMD Share Statistics

Avg. Volume (3 month) 19.37K USD
Avg. Daily Volume (10-Days) 11.95K USD
Shares Outstanding 81.35M
Float 30.91M
Short Ratio N/A
% Held by Insiders 43.55%
% Held by Institutions 0%
Shares Short N/A
Short % of Float N/A
Short % of Shares Outstanding N/A

Dividends & Splits

Trailing Annual Dividend Rate 0
Trailing Annual Dividend Yield 0%
5 Year Average Dividend Yield N/A
Payout Ratio 0
Last Split Factor

Financial Highlights

Fiscal Year

Fiscal Year Ends December 31, 2022
Most Recent Quarter (mrq) March 31, 2023
Next Fiscal Year End December 31, 2023

Profitability

Profit Margin 0%
Operating Margin (ttm) 0%
Gross Margin 0%
EBITDA Margin 0%

Management Effectiveness

Return on Assets (ttm) -278.91%
Return on Equity (ttm) N/A

Income Statement

Revenue (ttm) N/A
Revenue Per Share (ttm) N/A
Quarterly Revenue Growth (yoy) N/A
Gross Profit (ttm) N/A
EBITDA -148666 USD
Net Income Avi to Common (ttm) -101718 USD
Diluted EPS (ttm) 0
Quarterly Earnings Growth (yoy) N/A

Balance Sheet

Total Cash (mrq) 53.03K USD
Total Cash Per Share (mrq) 0.001 USD
Total Debt (mrq) 100K USD
Total Debt/Equity (mrq) N/A
Current Ratio (mrq) 0.393
Book Value Per Share (mrq) -0.001

Cash Flow Statement

Operating Cash Flow (ttm) -46508 USD
Levered Free Cash Flow (ttm) -196837 USD

Profile of Nu-Med Plus

Country United States
State NY
City Port Jefferson
Address 640 Belle Terre Road
ZIP 11777
Phone (631) 403-4337
Website https://www.nu-medplus.com
Industry Medical Devices
Sector(s) Healthcare
Full Time Employees 2

Nu-Med Plus, Inc., a medical device company, engages in the design, development, enhancement, and commercialization of medical devices worldwide. The company develops a hospital nitric oxide delivery system, a clinical nitric oxide delivery system, a mobile rechargeable device to deliver nitric oxide gas, and a nitric oxide system that can be used for research applications. It serves hospitals, health systems, and the medical community. The company was incorporated in 2011 and is based in New York, New York.

Q&A For Nu-Med Plus Stock

What is a current NUMD stock price?

Nu-Med Plus NUMD stock price today per share is 0.05 USD.

How to purchase Nu-Med Plus stock?

You can buy NUMD shares on the Other OTC exchange. Contact your financial advisor to select a broker.

What is the ticker symbol for Nu-Med Plus?

The stock symbol or ticker of Nu-Med Plus is NUMD.

Which industry does the Nu-Med Plus company belong to?

The Nu-Med Plus industry is Medical Devices.

How many shares does Nu-Med Plus have in circulation?

The max supply of Nu-Med Plus shares is 83.55M.

What is Nu-Med Plus Price to Earnings Ratio (PE Ratio)?

Nu-Med Plus PE Ratio is now.

What was Nu-Med Plus earnings per share over the trailing 12 months (TTM)?

Nu-Med Plus EPS is 0 USD over the trailing 12 months.

Which sector does the Nu-Med Plus company belong to?

The Nu-Med Plus sector is Healthcare.